3523-86-2

Basic information

• Product Name: 7-methylbenzo[c][1,2,5]oxadiazole 1-oxide
• Synonyms: 7-methylbenzo[c][1,2,5]oxadiazole 1-oxide
• CAS NO: 3523-86-2
• Molecular Formula: C₇H₆N₂O₂
• Molecular Weight: 150.13474
• Mol File: 3523-86-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-methylbenzo[c][1,2,5]oxadiazole 1-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: 7-methylbenzo[c][1,2,5]oxadiazole 1-oxide(3523-86-2)
• EPA Substance Registry System: 7-methylbenzo[c][1,2,5]oxadiazole 1-oxide(3523-86-2)

Safety Data

• Hazardous Substances Data: 3523-86-2(Hazardous Substances Data)

Upstream product

• 570-24-1 2-Methyl-6-nitroaniline 
• 601-87-6 3-methyl-2-nitroaniline 
• 16714-18-4 2-methyl-6-nitroazidobenzene 

Downstream Products

• 29091-40-5 4-methyl-benzo[1,2,5]oxadiazole 
• 32863-30-2 4-(bromomethyl)benzo[c][1,2,5]oxadiazole 

Relevant articles and documents

Biphenyl compound as well as preparation method and medical application thereof

The invention discloses a biphenyl compound as well as a preparation method and medical application thereof, the structure of the biphenyl compound is shown as a formula (I) or a formula (II), and thebiphenyl compound or pharmaceutically acceptable salt, tautomer, meso-isomer, raceme, stereoisomer, metabolite, metabolite precursor, prodrug or solvate thereof is a PD-L1 inhibitor. The compound hasa remarkable inhibiting effect on the interaction of PD-1 and PD-L1 protein, so that the compound can be applied to the preparation of PD-L1 inhibitors and immunomodulator drugs for preventing or treating tumors, autoimmune diseases, organ transplant rejection, infectious diseases and inflammatory diseases.

New analogs of nitrobenzylthioinosine

This invention relates to new analogs or derivatives of nitrobenzylthioinosine, use of these new analogs of nitrobenzylthioinosine for the treatment of pain and various other diseases as well as pharmaceuticals comprising at least on new analog of nitrobenzylthioinosine.